Study of ATH434 in Participants with Multiple System Atrophy
Study sponsor: Alterity Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-11-28Actual
Enrollment · participants77Actual
Source updated2024-12-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.